精品久久人妻av中文字幕,国产在线拍揄自揄视频不卡99,日韩在线观看高清视频亚洲成在人线a免费日本免费一区香蕉视频,亚洲毛片免费一级,国产又黄又硬又粗国产亚洲色婷婷久久99精品,国产又色又爽又刺激的视频,四虎成人精品在永久免费,激情国产AV做激情国产爱

Endovastec? Completes Acquisition of European Medical Device Company Optimum Medical

?On August 26, 2024, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (hereinafter referred to as “Endovastec?”) announced the completion of its acquisition of 72.37% equity in its associate company Optimum Medical Device Inc. (hereinafter referred to as “Optimum Medical”), a European medical device company. With the closing of this transaction, Optimum Medical has now become a wholly-owned subsidiary of Endovastec?. Optimum Medical owns two subsidiaries, Lombard Medical Limited and Lombard Medical Technologies GmbH (collectively referred to as “Lombard Medical”).

Endovastec? Announces Annual Results for 2023

On 27 March, 2024, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec?，Stock code: 688016.SH) announced the annual results of Endovastec? and its subsidiaries (the Company) for the 12 months ended 31 December, 2023 (the Reporting Period).

Endovastec? Completes Its First Implantation of Cratos? in Pre-Market Clinical Study in the EU and Japan

Recently, The Cratos? Branched Aortic Stent-Graft System (Cratos?), developed by Endovastec?, completed its first pre-market implantation at the University Hospital Zurich in Switzerland, as the starting of its CREATION clinical study. This study is instrumental for approval applications in the EU and Japan.